This is the first study in which it is documented that some of the perilesional hypoperfused tissue around human ICH regains its perfusion in the long term, leading the authors to suggest that there may be a penumbra in human ICH. Medical or surgical therapeutic interventions could increase the volume of perilesional brain that recovers after the initial insult. The results of this study therefore support the concept that intervention in ICH has the potential to reduce the ultimate neurological deficit and improve outcome.
Stroke welcomes Letters to the Editor and will publish them, if suitable, as space permits. They should not exceed 750 words (excluding references) and may be subject to editing or abridgment. Please submit letters in duplicate, typed double-spaced. Include a fax number for the corresponding author and a completed copyright transfer agreement form (published in the January and July issues). Hyperhomocysteinemia, MTHFR 677C3 T Polymorphism, and Stroke To the Editor:We welcome the report from Madonna and co-workers examining the role of prothrombotic and homocysteine (Hcy) pathway polymorphisms in risk of ischemic stroke in young adults. 1 We wish to comment on several issues raised by their article relating to the design of studies of genetic risk factors for complex phenotypes such as ischemic stroke, which we believe to be important when interpreting their findings. As the report points out, genetic predisposition to a complex human phenotype such as stroke is unlikely to be mediated by a large influence of 1 or 2 genes. Many observers agree that it is likely to result from a combination of relatively small individual effects of several genes, each predisposing to stroke via their influence on intermediate phenotypic traits, such as hypertension or hyperlipidemia. [2][3][4] This assumption has several implications for the design of epidemiological studies examining candidate genetic risk factors for stroke.First, given the small anticipated effect size associated with any single candidate polymorphism, the group sample sizes required to robustly demonstrate an association will be very large. This is important to avoid a potentially erroneous conclusion that no association exists (type 2 error). This point is particularly relevant in the case of the MTHFR 677C3 T polymorphism. Most prospective and retrospective studies to date have indicated that mildly elevated plasma Hcy is independently associated with ischemic stroke, and that the MTHFR TT genotype is associated with elevated Hcy. Paradoxically, most studies have not demonstrated an association between ischemic stroke and TT genotype. 5 One potential explanation for this apparent inconsistency is that the majority of studies lacked sufficient power to detect an association. Given a background rate of 17% in the general population, as reported in the article by Madonna and colleagues, and an anticipated relative risk of 20% associated with the TT genotype, we estimate that at least 1018 subjects per group are required to detect an effect with 80% power (␣ϭ0.05). The practical difficulties that this creates may be overcome by pooling data from multiple centers, or by employing alternative family-based designs, such as that currently underway by the NIH-funded Siblings With Ischemic Stroke Study (SWISS).Also, given the heterogeneity of underlying biological mechanisms predisposing to ischemic stroke, careful definition of stroke subtype and intermediate traits (eg, hypertension, atrial fibrillation) is important when studying candidate genetic polymorphisms. 2...
The Spiegelberg brain pressure catheter is a low cost implantable intracranial pressure measuring system which has the unique ability to perform regular automatic zeroing. A new version of the catheter has become available with a subdural bolt fixation to allow insertion of the device into the brain parenchyma. The accuracy of this system has been evaluated in comparison with a ventricular fluid pressure method in a series of patients to determine its accuracy and utility in the clinical environment.Hourly readings from the Spiegelberg system have been compared with those obtained using a standard pressure transducer connected to an external ventricular drain. Measurements continued while there was a clinical need for CSF drainage.Eleven patients were recruited to the study and data were recorded for periods ranging from 40 to 111 hours. A good agreement between the two systems was obtained. In 10 cases the mean diVerence was less than ±1.5 mm Hg and the dynamic changes in value were contemporaneous. In one case an intracerebral haemorrhage developed around the tips of the Spiegelberg catheter and significant diVerences occurred between the two methods of measurement.In conclusion, the Spiegelberg parenchymal transducer provides an accurate measurement of intracranial pressure when compared with ventricular pressure. The transducer was found to be robust in the clinical environment and very popular with the nursing staV. Further studies may determine whether the complication rate of this system is comparable with other available devices. (J Neurol Neurosurg Psychiatry 2001;71:383-385)
On the basis of these data the authors suggest that TICH and SICH have different features: TICH affects a slightly younger age group and carries a much better prognosis compared with SICH. In addition, indications for surgical intervention are not well defined for either type of hemorrhage. Practice is subjective and inconsistent. The International Surgical Trial in Intracerebral Haemorrhage may resolve the dilemma for SICH. A similar trial in which surgery is compared with conservative management should be considered for cases of TICH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.